Humoral and cellular immune response and the safety of third SARS-CoV-2 mRNA vaccine with longer interval after the second vaccination in kidney transplant recipients

We evaluated the humoral and cellular immune responses and safety of the third severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mRNA vaccine with a longer interval after the second vaccination in kidney transplant recipients (KTRs). We enrolled 54 kidney transplant recipients without a h...

Descripción completa

Detalles Bibliográficos
Autores principales: Takai, Satoshi, Nishida, Hayato, Ito, Hiromi, Fukuhara, Hiroki, Nawano, Takaaki, Narisawa, Takafumi, Kanno, Hidenori, Yagi, Mayu, Yamagishi, Atsushi, Sakurai, Toshihiko, Naito, Sei, Kato, Tomoyuki, Morikane, Keita, Tsuchiya, Norihiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747938/
https://www.ncbi.nlm.nih.gov/pubmed/36532067
http://dx.doi.org/10.3389/fimmu.2022.1050211

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747938/
https://www.ncbi.nlm.nih.gov/pubmed/36532067
http://dx.doi.org/10.3389/fimmu.2022.1050211

Ejemplares similares